Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, Fölster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U. Luger T, et al. Pediatr Allergy Immunol. 2015 Jun;26(4):306-15. doi: 10.1111/pai.12331. Epub 2015 Apr 13. Pediatr Allergy Immunol. 2015. PMID: 25557211 Free PMC article. Review.
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.
Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sönnichsen N, Czech W, Kapp A, Stege H, Grewe M, Schöpf E. Krutmann J, et al. Among authors: luger ta. J Am Acad Dermatol. 1998 Apr;38(4):589-93. doi: 10.1016/s0190-9622(98)70123-9. J Am Acad Dermatol. 1998. PMID: 9555799 Clinical Trial.
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.
Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield LF, Ferrandiz C, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH; ICCAD II Faculty. Ellis C, et al. Among authors: luger t. Br J Dermatol. 2003 May;148 Suppl 63:3-10. doi: 10.1046/j.1365-2133.148.s63.1.x. Br J Dermatol. 2003. PMID: 12694268 Free article. Review. No abstract available.
Consensus conference on pediatric atopic dermatitis.
Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Eichenfield LF, et al. J Am Acad Dermatol. 2003 Dec;49(6):1088-95. doi: 10.1016/s0190-9622(03)02539-8. J Am Acad Dermatol. 2003. PMID: 14639390 Review. No abstract available.
Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M, Steinhoff M, Schneider D, Luger TA. Grassberger M, et al. Among authors: luger ta. Exp Dermatol. 2004 Dec;13(12):721-30. doi: 10.1111/j.0906-6705.2004.00269.x. Exp Dermatol. 2004. PMID: 15560755 Review.
Consensus statement on the safety profile of topical calcineurin inhibitors.
Bieber T, Cork M, Ellis C, Girolomoni G, Groves R, Langley R, Luger T, Meurer M, Murrell D, Orlow S, Paller A, de Prost Y, Puig L, Ring J, Saurat JH, Schwarz T, Shear N, Stingl G, Taieb A, Thestrup-Pedersen K; Pediatric Advisory Committee of the Food and Drug Administration. Bieber T, et al. Among authors: luger t. Dermatology. 2005;211(2):77-8. doi: 10.1159/000086431. Dermatology. 2005. PMID: 16088148 No abstract available.
761 results